一覧に戻る

タイトル
  • ja Gamma-interferon-inducible, lysosome/endosome-localized thiolreductase, GILT, has anti-retroviral activity and its expression is counteracted by HIV-1
作成者
    • Kubo, Yoshinao
    • Izumida, Mai
    • Yashima, Yuka
    • Yoshii-Kamiyama, Haruka
    • Tanaka, Yuetsu
    • Yasui, Kiyoshi
    • Hayashi, Hideki
    • Matsuyama, Toshifumi
権利情報
  • c 2016 Impact Journals, LLC
  • This article is licensed under a Creative Commons Attribution 3.0 License.
主題
  • Other Antiviral
  • Other Endosome
  • Other Gamma-interferon
  • Other Retroviruses
  • Other Thiolreductase
内容注記
  • Other The mechanism by which type II interferon (IFN) inhibits virus replications remains to be identified. Murine leukemia virus (MLV) replication was significantly restricted by γ-IFN, but not human immunodeficiency virus type 1 (HIV-1) replication. Because MLV enters host cells via endosomes, we speculated that certain cellular factors among γ-IFN-induced, endosome-localized proteins inhibit MLV replication. We found that γ-IFN-inducible lysosomal thiolreductase (GILT) significantly restricts HIV- 1 replication as well as MLV replication by its thiolreductase activity. GILT silencing enhanced replication-defective HIV-1 vector infection and virion production in γ-IFNtreated cells, although γ-IFN did not inhibit HIV-1 replication. This result showed that GILT is required for the anti-viral activity of γ-IFN. Interestingly, GILT protein level was increased by γ-IFN in uninfected cells and env-deleted HIV-1-infected cells, but not in full-length HIV-1-infected cells. γ-IFN-induced transcription from the γ-IFNactivation sequence was attenuated by the HIV-1 Env protein. These results suggested that the γ-IFN cannot restrict HIV-1 replication due to the inhibition of γ-IFN signaling by HIV-1 Env. Finally, we found that 4,4'-dithiodipyridine (4-PDS), which inhibits S-S bond formation at acidic pH, significantly suppresses HIV-1 vector infection and virion production, like GILT. In conclusion, this study showed that GILT functions as a host restriction factor against the retroviruses, and a GILT mimic, 4-PDS, is the leading compound for the development of novel concept of anti-viral agents.
  • Other identifier:Oncotarget, 7(44), pp.71255-71273; 2016
出版者 Impact Journals LLC
日付
    Created2020-12-21 , Issued2016-09-18
言語
  • eng
資源識別のタイプ journal article
出版タイプ VoR
資源識別子 URI http://hdl.handle.net/10069/37356
関連
  • isIdenticalTo DOI https://doi.org/10.18632/oncotarget.12104
収録誌情報
    • ISSN 1949-2553
      • Oncotarget 7(44), 71255-71273
ファイル
コンテンツ更新日時 2021-02-17